# Tenaya Therapeutics, Inc.: Form 8-K, filed Jan 2, 2026

- Company: [Tenaya Therapeutics, Inc.](/companies/tnya.md) (CIK 1858848)
- Form: 8-K
- Filed: 2026-01-02
- Accepted by EDGAR: Jan 2, 2026, 22:10 ET
- Period: 2025-12-31
- Accession: 0001193125-26-001065
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1858848/000119312526001065/tnya-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1858848/000119312526001065/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1858848/000119312526001065/tnya-20251231.htm

Filed Jan 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-001065. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.